Work

A novel anti-GD2 monoclonal antibody (mAb), hu14.18K322A, in children with refractory or recurrent neuroblastoma: Early-phase evaluation.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.9523

Authors: F. Navid, R. C. Barfield, R. Handgretinger, P. M. Sondel, B. L. Shulkin, R. Kaufman, C. Billups, J. Wu, W. L. Furman, L. M. McGregor, M. Otto, S. Gillies, V. M. Santana

Institutions: St. Jude Children's Research Hospital, University of Wisconsin–Madison, University Children's Hospital Tübingen, Duke Medical Center, University of Tübingen

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591024476

Cites:

Cited by: 7

Related to: 10